Bereket Abraha Molla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bereket Abraha Molla has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Gebeyehu Tessema Azibte
Department of Internal Medicine, College of Medicine and Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
5 shared publications - Sebhatleab Teju Mulate
Addis Ababa University College of Health Sciences
4 shared publications - Zekarias Seifu Ayalew
Department of Internal Medicine Addis Ababa University Addis Ababa Ethiopia
3 shared publications - Abdurrhman Kedir Hamza
Department of Pathology, Addis Ababa University, Addis Ababa, Ethiopia
1 shared publication Berhanu M. Abera
Department of Internal Medicine College of Health Science, Addis Ababa University Addis Ababa Ethiopia
1 shared publication- Biruk Abate Legesse
Department of Internal Medicine, Addis Ababa University, Addis Ababa, Ethiopia
1 shared publication
Latest Publications
- 8 May 2026
- Published by Elsevier in Next Research
- Vol. 10
Cryptococcal meningitis in cirrhosis: navigating diagnostic and therapeutic challenges in a resource-limited setting
- 8 May 2026
- Published by Elsevier in Next Research
- Vol. 10
Cryptococcal meningitis in cirrhosis: navigating diagnostic and therapeutic challenges in a resource-limited setting
- Open Access
- 7 February 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (2) , e70180
A Case Report of Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatment in Resource‐Limited Setup: An Ethiopian Experience
MOSD is a rare and disabling immune‐mediated inflammatory Astrocytopathic disease characterized by demyelination and axonal destruction, typically involving the spinal cord and the optic nerve. Here we present a case report of a 53‐year‐old female patient who had a pertinent history of treatment for optic neuritis a few months back, currently diagnosed with Neuromyelitis Optica after she presented with a three‐week history of weakness of lower extremity, headache, and neuropathic pain. She was pulsed with methylprednisolone and started on azathioprine, which significantly improved her clinical condition. When patients with optic neuritis and transverse myelitis occur, a high index of suspicion for NMOSD is essential. Establishing a diagnosis based on clinical and MRI findings is crucial for initiating therapy quickly, halting more harm, and avoiding a delay in diagnosis. Our experience treating our patient shows that Azathioprine is still a practical choice in resource‐limited setups.
- 7 February 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (2) , e70180
Open AccessA Case Report of Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatment in Resource‐Limited Setup: An Ethiopian Experience
MOSD is a rare and disabling immune‐mediated inflammatory Astrocytopathic disease characterized by demyelination and axonal destruction, typically involving the spinal cord and the optic nerve. Here we present a case report of a 53‐year‐old female patient who had a pertinent history of treatment for optic neuritis a few months back, currently diagnosed with Neuromyelitis Optica after she presented with a three‐week history of weakness of lower extremity, headache, and neuropathic pain. She was pulsed with methylprednisolone and started on azathioprine, which significantly improved her clinical condition. When patients with optic neuritis and transverse myelitis occur, a high index of suspicion for NMOSD is essential. Establishing a diagnosis based on clinical and MRI findings is crucial for initiating therapy quickly, halting more harm, and avoiding a delay in diagnosis. Our experience treating our patient shows that Azathioprine is still a practical choice in resource‐limited setups.
- Open Access
- 7 August 2024
- Published by Elsevier in Radiology Case Reports
- Vol. 19 (10) , 4644-4649
Primary central nervous system lymphoma: A diagnostic challenge in a young immunocompetent patient with limited resources
- 7 August 2024
- Published by Elsevier in Radiology Case Reports
- Vol. 19 (10) , 4644-4649
Open AccessPrimary central nervous system lymphoma: A diagnostic challenge in a young immunocompetent patient with limited resources
- Open Access
- 3 July 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (7) , e9142
Multiple system atrophy—cerebellar type: Diagnostic challenge in resource‐limited settings case report
Key Clinical Message: This case report highlights the challenges of diagnosing MSA‐C in resource‐limited settings. MRI findings like the “hot cross bun” sign can be supportive, but the unavailability of advanced tools like seed amplification assay may delay diagnosis. Early diagnosis is crucial for proper symptom management. Multiple system atrophy is a rare neurodegenerative disorder affecting the pyramidal, autonomic, nigrostriatal, and cerebellar tracts. Multisystem atrophy should be considered in adults with progressive motor or autonomic dysfunctions. Clinical manifestations vary depending on the system, including bradykinesia, tremor, rigidity, cerebellar ataxia, and autonomic failure. Depending on the initial predominant manifestation, multisystem atrophy is classified as Parkinsonian (MSA‐P) and cerebellar (MSA‐C). Our patient presented with progressive loss of balance, rigidity, slurred speech, choking episodes, and loss of morning tumescence for 4 years, suggesting autonomic and cerebellar involvement. He was diagnosed with MSA after 4 years of initial presentation with combinations of magnetic resonant imaging findings and clinical manifestations. Diagnosing multiple system atrophy in such resource‐limited areas is challenging. The unavailability of seed application tests and biomarkers significantly affected the delayed diagnosis.
- 3 July 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (7) , e9142
Open AccessMultiple system atrophy—cerebellar type: Diagnostic challenge in resource‐limited settings case report
Key Clinical Message: This case report highlights the challenges of diagnosing MSA‐C in resource‐limited settings. MRI findings like the “hot cross bun” sign can be supportive, but the unavailability of advanced tools like seed amplification assay may delay diagnosis. Early diagnosis is crucial for proper symptom management. Multiple system atrophy is a rare neurodegenerative disorder affecting the pyramidal, autonomic, nigrostriatal, and cerebellar tracts. Multisystem atrophy should be considered in adults with progressive motor or autonomic dysfunctions. Clinical manifestations vary depending on the system, including bradykinesia, tremor, rigidity, cerebellar ataxia, and autonomic failure. Depending on the initial predominant manifestation, multisystem atrophy is classified as Parkinsonian (MSA‐P) and cerebellar (MSA‐C). Our patient presented with progressive loss of balance, rigidity, slurred speech, choking episodes, and loss of morning tumescence for 4 years, suggesting autonomic and cerebellar involvement. He was diagnosed with MSA after 4 years of initial presentation with combinations of magnetic resonant imaging findings and clinical manifestations. Diagnosing multiple system atrophy in such resource‐limited areas is challenging. The unavailability of seed application tests and biomarkers significantly affected the delayed diagnosis.
- Open Access
- 28 April 2024
- Published by Science Publishing Group in International Journal of Diabetes and Endocrinology
- Vol. 9 (2) , 46-55
Risk Factors for Ten-Year Risk of Osteoporosis in Type 2 DM Patients Attending Tikur Anbessa Specialized Hospital Diabetic Center Cross-sectional Study
Background : Type 2 diabetes mellitus (T2DM) is a major contributing factor to osteoporotic fractures via different mechanisms. This study assessed the ten-year risk of osteoporosis and associated factors for osteoporotic fractures in T2DM patients. Methods : Data from 175 type diabetes mellites (T2DM) patients over 40 years attending a diabetes clinic at Tikur Anbessa Specialized Hospital (TASH) were collected. Demographic information, diabetic complications, blood sugar levels, and other medical illnesses were collected by a structured questionnaire and from an electronic medical record system. The 10-year fracture risk assessment (FRAX) tool was used without bone mineral density (BMD) measurement. multivariate logistic regression was used to analyze factors associated with fragility fractures. Results : Half the participants were female, with a median age of 60. Most were married, well-educated, and urban residents. The median duration of diabetes was 11 years. The median FRAX score indicated a moderate 10-year risk of hip fracture (≥3%) and a high risk of major osteoporotic fracture (≥20%). Overall, 30.9% of patients had a high 10-year risk of osteoporotic fracture. The majority (78.3%) had macrovascular complications, with neuropathy, retinopathy, and nephropathy being the common ones. Higher FBS, higher HbA1c, and the presence of macrovascular complications were significantly associated with a higher risk of fractures. Conclusion : This study found a high prevalence (30.9%) of a 10-year risk of osteoporotic fractures in T2 DM patients. Poor glycemic control (higher HbA1c and FBS) and the presence of macrovascular complications were significantly associated with an increased 10-year osteoporotic fracture risk.
- 28 April 2024
- Published by Science Publishing Group in International Journal of Diabetes and Endocrinology
- Vol. 9 (2) , 46-55
Open AccessRisk Factors for Ten-Year Risk of Osteoporosis in Type 2 DM Patients Attending Tikur Anbessa Specialized Hospital Diabetic Center Cross-sectional Study
Background : Type 2 diabetes mellitus (T2DM) is a major contributing factor to osteoporotic fractures via different mechanisms. This study assessed the ten-year risk of osteoporosis and associated factors for osteoporotic fractures in T2DM patients. Methods : Data from 175 type diabetes mellites (T2DM) patients over 40 years attending a diabetes clinic at Tikur Anbessa Specialized Hospital (TASH) were collected. Demographic information, diabetic complications, blood sugar levels, and other medical illnesses were collected by a structured questionnaire and from an electronic medical record system. The 10-year fracture risk assessment (FRAX) tool was used without bone mineral density (BMD) measurement. multivariate logistic regression was used to analyze factors associated with fragility fractures. Results : Half the participants were female, with a median age of 60. Most were married, well-educated, and urban residents. The median duration of diabetes was 11 years. The median FRAX score indicated a moderate 10-year risk of hip fracture (≥3%) and a high risk of major osteoporotic fracture (≥20%). Overall, 30.9% of patients had a high 10-year risk of osteoporotic fracture. The majority (78.3%) had macrovascular complications, with neuropathy, retinopathy, and nephropathy being the common ones. Higher FBS, higher HbA1c, and the presence of macrovascular complications were significantly associated with a higher risk of fractures. Conclusion : This study found a high prevalence (30.9%) of a 10-year risk of osteoporotic fractures in T2 DM patients. Poor glycemic control (higher HbA1c and FBS) and the presence of macrovascular complications were significantly associated with an increased 10-year osteoporotic fracture risk.
- Open Access
- 9 March 2024
- Published by Wiley
Multiple system atrophy cerebellar type
A document by Gebeyehu Azibte. Click on the document to view its contents.
- 9 March 2024
- Published by Wiley
Open AccessMultiple system atrophy cerebellar type
A document by Gebeyehu Azibte. Click on the document to view its contents.